1832 Asset Management L.P. Arrowhead Pharmaceuticals, Inc. Transaction History

1832 Asset Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$20.56 - $63.12 $11.2 Million - $34.3 Million	-543,940 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$28.14 - $73.01 $1.95 Million - $5.05 Million	-69,160 Reduced 11.28%	543,940 $34.4 Million
Q3 2019 Nov 14, 2019	BUY	$26.26 - $34.86 $14.3 Million - $19 Million	543,900 Added 785.98%	613,100 $16.2 Million
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $1.21 Million - $1.99 Million	69,200 New	69,200 $2 Million

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.